Halozyme Therapeutics Inc (HALO)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	1,015,324	947,355	873,304	862,989	829,253	780,710	773,653	704,980	660,116	580,623	487,477	471,567	443,310	463,010	412,496	331,262	267,594	199,556	180,470	164,397
Total assets	US$ in thousands	2,063,480	2,118,030	1,969,450	1,841,530	1,733,270	1,892,660	1,810,440	1,699,450	1,841,510	1,864,540	1,781,390	1,162,250	1,104,430	1,185,420	1,025,860	966,582	579,924	524,029	526,997	492,353
Total asset turnover		0.49	0.45	0.44	0.47	0.48	0.41	0.43	0.41	0.36	0.31	0.27	0.41	0.40	0.39	0.40	0.34	0.46	0.38	0.34	0.33

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $1,015,324K ÷ $2,063,480K
= 0.49

Total asset turnover measures how efficiently a company utilizes its assets to generate revenue. A higher total asset turnover indicates better asset utilization.

Based on the data provided for Halozyme Therapeutics Inc, we observe fluctuations in the total asset turnover ratio over the periods. The ratio increased from 0.33 in March 2020 to 0.49 in December 2024, which suggests an improvement in the efficiency of asset utilization during this period.

However, it's worth noting that there were fluctuations in the ratio over the quarters, indicating possible changes in the company's operations, sales dynamics, or asset management strategies. For example, the ratio reached its lowest point of 0.27 in June 2022 but gradually recovered and peaked at 0.49 in December 2024.

Overall, Halozyme Therapeutics Inc's total asset turnover demonstrates a mixed performance, with some periods showing improved asset utilization efficiency compared to others. It would be beneficial to monitor this ratio continuously to assess the company's ongoing operational efficiency and effectiveness in utilizing its assets to generate revenue.